β-Adrenergic Receptor-Mediated Cardiac Contractility is Inhibited via Vasopressin Type 1A-Receptor-Dependent Signaling

BACKGROUND: Enhanced arginine vasopressin (AVP) levels are associated with increased mortality during end-stage human heart failure (HF), and cardiac AVP type 1A receptor (V1AR) expression becomes increased. Additionally, mice with cardiac-restricted V1AR overexpression develop cardiomyopathy and de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circulation
Main Authors: Tilley, Douglas G., Zhu, Weizhong, Myers, Valerie D., Barr, Larry A., Gao, Erhe, Li, Xue, Song, Jianliang, Carter, Rhonda L., Makarewich, Catherine A., Yu, Daohai, Troupes, Constantine D., Grisanti, Laurel A., Coleman, Ryan C., Koch, Walter J., Houser, Steven R., Cheung, Joseph Y., Feldman, Arthur M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4229385/
https://ncbi.nlm.nih.gov/pubmed/25205804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.114.010434
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados